Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-02-23 @ 1:52 PM
Study NCT ID:
NCT06454266
Status:
COMPLETED
Last Update Posted:
2024-07-30
First Post:
2024-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)
Sponsor:
Ningbo No. 1 Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-25
Completion Date Type:
ACTUAL
First Submit Date:
2024-05-05
First Submit QC Date:
None
Study First Post Date:
2024-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-28
Last Update Post Date:
2024-07-30
Last Update Post Date Type:
ACTUAL